Academic-Industry Partnership Symposium Presented by: Blank Rome LLP

Slides:

Advertisements

Similar presentations

David M. Pollock Medical College of Georgia Discovery-Academia.

Advertisements

Consortium québécois sur la découverte du médicament Facilitating creative partnerships in biopharmaceutical research Ottawa, November 30 th, 2009 Diane.

University Contracting The University of Arizona Office of Research and Contract Analysis (ORCA)

 Finding the Right Company Active role in identifying external POC funds (internal funding, Science Center, Ben Franklin, BioAdvance, BioStrategy Partners)

University Contracting The University of Arizona Contracting & Research Services (CRS)

Personal financial benefit or economic interest from one’s position that may inappropriately: influence the employee’s judgment compromise the employee’s.

The Open Innovation Center Susie Stephens, Principal Research Scientist, Eli Lilly.

Technology and Economic Development Intellectual Property Issues in Research Jim Baker Director Office of Technology and Economic Development

Lund University Innovation System LU Innovation System THE LINK BETWEEN BUSINESS AND ACADEMIA.

South Carolina Research Universities An Assessment of Commercialization and Entrepreneurial Activities.

Intellectual Property Rights Margaret Lawlor Business Development Manager Faculty of Medical Sciences 2015 copyright©NewcastleUniversity 2015.

Creation of IP Culture in Universities & Advantages of Universities having an IP Culture Dr Duncan Matthews Queen Mary University of London.

LOWER SHORE TECHNOLOGY TRANSFER SYMPOSIUM Bringing the Benefits of Discovery to the World MAY 23, 2012 Wesley D. Blakeslee Executive Director Johns Hopkins.

ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH Anantha Shekhar MD, PhD Indiana University School of Medicine Indiana Clinical and.

EXPRESS LICENSE AGREEMENTS Ted Hagelin Crandall Melvin Professor of Law Kauffman Professor of Entrepreneurship and Innovation Director, NY Science & Technology.

Technology Transfer University of Colorado Denver Rick Silva, Ph.D., M.B.A. -- Director Senior Licensing Managers David Poticha, M.S., J.D. Paul Tabor,

Green Manufacturing Industrial Consortium Western Michigan University David Meade, PhD., Associate Director.

What we ask in a ROI What it is? Is it related to another invention? Who contributed to making the invention? Who paid for the research? When invention.

Starting a Company from Research at the UW James A. Severson, Ph.D. Vice Provost, Intellectual Property and Technology Transfer January 30, 2007.

1 Enterprise Ireland Innovation, Research Commercialisation (IRC) Commercialisation Workshop – Ideas to Industry.

Strengths and Gaps in the Canadian Vaccine Landscape: a biotech perspective Nathalie Charland, PhD Sr. Director, Scientific liaisons Vaccine Innovation.

February 25, 2014 SERIES 4, SESSION 2 OF AAPLS APPLICANTS & ADMINISTRATORS PREAWARD LUNCHEON SERIES Material Transfer and Confidentiality Agreements.

Serving Canadian Business in Canada and Abroad. l A global trade service –part of International Trade Canada –150 offices abroad and 12 regional offices.

Lowell Smith Sr. Director, Business & Communications Research Administration.

IP for Scientists Universities Allied for Essential Medicines (UAEM) UC Berkeley.

The Academia-Industry Marriage: How to get the I do! The Promise of Innovation Montserrat Capdevila Director of Sales, Marketing, and International Relations.

WIPO Dispute Resolution in International Science & Technology April 25, 2005 Ann M. Hammersla Senior Counsel, Intellectual Property Massachusetts Institute.

Online Technology Marketplaces and Technology Brokers – Insights on how they can work for you Denise Lalanne June 18, 2004.

INDUSTRY SPONSORED RESEARCH David Erem University of Kentucky Office of Sponsored Programs.

Technology Transfer at Brookhaven SPAFOA MEMBERS’ MEETING May 21, 2015.

University Contracting The University of Arizona Office of Research and Contract Analysis (ORCA)

A Dual Role Principal (Rector) of Heriot-Watt University Chair of the regional economic development company.

Polimi Case study: Procedures, tools, facts & Figures

Relationship of FFSP to the Florida Agricultural Experiment Station John P. Hayes August 6, 2012.

1 Knowledge | Innovation | Technology Overview of Risk Management in University Technology Transfer David N. Allen, Ph.D. Associate Vice President for.

Technology Transfer Center of the University of Lodz High-Tech Accelerator - Innovation Center Foundation of the University of Lodz Bridging science and.

NOVEMBER 13, 2012 SERIES 2, SESSION XI OF APPLICANTS & ADMINISTRATORS PREAWARD LUNCHEON SERIES Research Sponsored by Industry – Putting an Agreement in.

USC Stevens at a Glance Navigating the University August 19, 2014.

Introduction to the Offices of Biotechnology & Business Development John L. Harb Director, Office of Biotechnology __________________________________ October.

Policies Promoting IP Development in Universities and Higher Institutions of Learning In Africa OGADA Tom WIPO National Workshop on Intellectual Property.

Elements of a Workable Intellectual Property Policy OPIC IP Roundtable Noel Courage Bereskin & Parr November 21, 2007.

1 WIPO – Geneva – April 2005 European Commission – Research DG D. Dambois European Patent Attorney IPR disputes in international.

Commons, Networks, and Technology Transfer Gerald Barnett Director, Intellectual Property Management University of California, Santa Cruz.

Ignite Technology Transfer NUI Galway Technology Transfer Office Seamus Coyne, Ph.D Neil Ferguson, Ph.D Commercialisation Executives Technology Transfer.

1 Columbia University Office of the General Counsel March 2012 Columbia University Office of the General Counsel Patenting Biotech: Strategies and Tips.

Translation and Innovation Mark Chance, PhD Vice Dean for Research School of Medicine October 19, 2015.

Academic Technology Transfer Operations and Practice Knowledge Economy Forum IV Istanbul, Turkey March 22-25, 2005 Alistair Brett Oxford Innovation.

NATIONAL CONFERENCE Intellectual Property Policies for Universities and Innovation dr. sc. Vlatka Petrović Head, Technology Transfer Office Acting Head,

Policy on the Management of Intellectual Property in Technology Transfer Activities at CERN CERN/FC/5434/RA Technology Transfer Network Meeting – 10 th.

Why an Intellectual Property Policy? Sofia, November 24 and 25, 2015 Mr. Evgeniy Sesitsky, Department for Transition and Developed Countries, World Intellectual.

Technology transfer – The Hungarian experience Legal background Innovation Act: - Public R&D institutions are required to establish IP policy - IP created.

Vermont's 21st Century Economy: Building an Entrepreneurial Ecosystem Dr. Corine Farewell Director, Office of Technology Commercialization University of.

+ Departmental Research Administrator Training Series An Introduction to Contracts and OCIA James J. Casey, Jr., J.D. Director, Office of Contracts and.

Review of Research-Related Agreements Between Academic Institutions and Other Entities. Manoja Ratnayake Lecamwasam, PhD Intellectual Property and Innovation.

A model collaboration using the Pool Susanne Hollinger, Ph.D., J.D. Chief Intellectual Property Officer Emory University.

HEPTech G. Anelli (CERN) On behalf of the HEPTech Management Team 24 th March 2015.

Technology Transfer Office

Technology Transfer Office

Five Steps To Effective Research Proposals

Office of Technology Commercialization (OTC)

Towards a roadmap for collaborative R&D

Universities and the Commercial World

SUNY Industry Engagement and Economic Development

Partnering with Business and Industry

تجاری سازی تحقیقات دانشگاهی

Application and Presentation to the

Intellectual Property &Technology Transfer

BUFFALO FUND: ACCELERATOR Full Proposal Presentation

Proposal Presentation to the

Humboldt Space Research Mission America. Humboldt Space Co. adopts a forward thinking stance in scientific research and technical development. Our policy.

Presentation transcript:

Academic-Industry Partnership Symposium Presented by: Blank Rome LLP

The mission of PhIND is to create a collaborative research organization that attracts excellent scientists, accelerates the pace of research on neurodegenerative disorders, and establishes a leading, internationally-recognized center of Neuroscience discovery and development.

Panel Members Todd Abrams, PhD – BioStrategy Partners Gordon Lutz, PhD – LifeSplice Pharma, LLC Stephen Nappi – Temple University David Gitlin, Esq. – Blank Rome LLP Ezra Felker – Nupathe Inc. John Reid, PhD, MBA – AstraZeneca

Barriers to Collaboration Ecosystem member Member associated barriers Principal Investigator/ Inventor Not interested in performing industry focused experiments (Identified by Industry) Not informed about IP and commercialization (identified by Industry and TTO) PI signs agreements (identified by TTO) No promotions for inventing (traditional barrier) Management and urgency of data (Identified by Industry) Technology Transfer Office Lack of resources for IP and commercialization (TTO barrier) Multiple offices review documents (TTO barrier) Mismatch of expectations (traditional Industry barrier) Patent Policy not considered legally binding by PI (PI identified)

Barriers to Collaboration Ecosystem member Member associated barriers Legal Research agreements aligned to one side or the other due to legal representative (traditional barrier) Long review and over-engineered documents (general comment) Solution Academia associated barriers Third parties assist TTO and investigator to explain commercialization issues Legal informs investigator IP policy is binding and no agreements outside University are permitted Develop common agreements with compromise language Sets expectations. Permits focus on the commercialization plan Reduces legal review time

Barriers to Collaboration Ecosystem member Member associated barriers Biotech and Pharmaceutical Industry Intellectual Property rights for improvement and related inventions (self identified, TTO and Legal) ROI and academic expectations do not match (general barrier) On time on budget (i.e. urgency of data) (for TTO and PI) Solution industry barriers Reward all innovation through planned co-development Match investment with results Make sure termination provisions are comprehensive

New Models of Collaboration “Drug discovery on campus” one to one industry to University relationships with a new purpose Disease focus interest groups model (PhIND, Philly Derm) Consortium Model Regional technology exchange (Science Center – QED) Example models: Coulter; MaRS District, CPATH New Barriers: New purpose of research; Complex agreements including financial, IP, operations and governance issues different from sponsored research

New Models of Collaboration Key points of Discussion: Agreements some proprietary information such as compounds and targets not shared Shared resource opportunities Follow on research milestone based to reward success Avoid IP argument by company having license to IP and data related to company compounds Provisions to rewards academic innovation Key to success: dedicated project and alliance management

Q & A dfa Thank you for your support!

www.PhINDResearch.org